US · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS · SMALL CAP
Hongchang International Co. Ltd. HCIL
15 fiscal years on record · USD · FY2024 reported
SEC FILINGS ONLY
Revenue · FY2024
$2.9M
▲ 7.1% vs FY2023
EPS · FY24
$0.00
Dividend / sh · FY24
—
Payout · FY24
—
ROE · FY24
-1.2%
Net margin · FY24
-16.5%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 2.9M
Revenue, FY2024 · full 15-year series below
Revenue
Net income
The company lost 16 cents on every revenue dollar this year.
Per share
USD 0.00
Diluted EPS, FY2024
EPS
The company pays no cash dividend.
Profitability
-1.2%
Return on equity, FY2024
ROE
Operating margin-13.4%
Net margin-16.5%
Return on assets-0.9%
Each USD of equity lost 1 cents this year.
Returned to shareholders
—
returned in FY2024 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+77.3% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+209.7%
+77.3%
−8.0%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.52B
Shares outstanding, FY2024
Change, 5 years−34.7%
Change, 10 years—
The share count shrank 35% in five years — the same company, cut into fewer, larger slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 57.5M
total assets, end of FY2024
Total assetsUSD 57.5M
EquityUSD 38.8M
CashUSD 240,598.00
Gross debtUSD 6.8M
Net debtUSD 6.6M
Current ratio1.21×
Net debt stands at 17% of equity.
History
15 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Revenue $B
0.0
0.0
0.0
0.0
0.0
0.0
·
·
0.0
0.0
0.0
0.0
0.0
0.0
·
Operating income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
EBITDA $B
−0.0
−0.0
−0.0
·
·
·
·
·
·
−0.0
·
·
·
−0.0
0.0
Income tax $B
−0.0
−0.0
·
·
·
·
·
·
·
·
·
−0.0
0.0
−0.0
0.0
Net income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
EPS, diluted $
0.00
0.00
0.00
0.00
·
0.00
0.00
0.00
0.00
−0.07
−0.01
−0.07
−0.02
−0.02
0.00
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
−1.2
−1.9
·
·
·
·
·
·
·
−95.7
−12.6
−61.0
−9.8
−10.9
0.5
Shares out B
0.52
0.52
0.42
1.03
0.00
1.03
1.14
0.03
0.05
0.05
0.05
0.05
0.05
0.05
0.05
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
45 of 45
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed